Attenuation Imaging in Hepatic Steatosis

Noninvasive Assessment of Hepatic Steatosis by Using Attenuation Imaging in Children

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05302258

Enrollment

120

Registered

2022-03-31

Start date

2022-04-14

Completion date

2022-12-14

Last updated

2022-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic Steatosis, Obesity, Childhood, Ultrasonography

Brief summary

For obese and normal-weight children, the investigators assess the diagnostic performance of attenuation imaging (ATI) in the detection of hepatic steatosis in children.

Interventions

DIAGNOSTIC_TESTAttenuation imaging in ultrasonography

Attenuation imaging in ultrasonography

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

5 Years to 17 Years

Healthy volunteers

Yes

Inclusion criteria

* BMI of 85th percentile or less

Exclusion criteria

* congenital anomaly including heart, intestine, kidney * acute hepatitis * congenital hepatic anomaly

Design outcomes

Primary

Measure	Time frame	Description
Diagnostic performance of attenuation imaging	through study completion, an average of 1 year	The diagnostic performance of attenuation imaging in US in the detection of hepatic steatosis

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026